Evidence map›Paper›PMID 23773928›Full record

ReviewFEBS letters2013

Redox modification of proteins as essential mediators of CNS autophagy and mitophagy.

Britney Lizama-Manibusan, Bethann McLaughlin

Open access · bronzeAbstract readReview
In one paragraph

Review in FEBS letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease.Movement disorders : official journal of the Movement Disorder Society · 2015
    Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Cancer Therapy by Silver Nanoparticles: Fiction or Reality?International journal of molecular sciences · 2022
    Review
  7. The Peroxisome-Autophagy Redox Connection: A Double-Edged Sword?Frontiers in cell and developmental biology · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Britney Lizama-ManibusanVanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37221, USA.
Bethann McLaughlin
Vanderbilt University · US

Funding

ASK signalosomes and environmental sensingR01ES022936 · NIEHS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MCLAUGHLIN, BETHANN M · 2014 to 2018
$1.8M
NIEHS NIH HHS R01 ES022936
6 · The paper itself

Abstract

Production of cellular reactive oxygen species (ROS) is typically associated with protein and DNA damage, toxicity, and death. However, ROS are also essential regulators of signaling and work in concert with redox-sensitive proteins to regulate cell homeostasis during stress. In this review, we focus on the redox regulation of mitophagy, a process that contributes to energetic tone as well as mitochondrial form and function. Mitophagy has been increasingly implicated in diseases including Parkinson's, Amyotrophic Lateral Sclerosis, and cancer. Although these disease states employ different genetic mutations, they share the common factors of redox dysregulation and autophagic signaling. This review highlights key redox sensitive signaling molecules which can enhance neuronal survival by promoting temporally and spatially controlled autophagic signaling and mitophagy.

Indexed as

AutophagyMitophagyAnimalsCentral Nervous SystemHumansOxidation-ReductionProteinsReactive Oxygen SpeciesSignal TransductionProteinsReactive Oxygen SpeciesAmyotrophic lateral sclerosisAtgEnergeticsFOXOHIFIsocitrate dehydrogenaseMitochondriaMitophagyNeurodegenerationp66shcParkinson’s diseaseReactive oxygen speciesSirtuin

Identifiers

PMID23773928
PMCPMC5125300
OpenAlexW2137780815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.